Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Working Life: Maneesh Juneja

April 3, 2009 Research and Development GSK, productivity

How did you find your way into your current role? After graduating with a degree in business & computing, I …
Feature

Telehealth awareness reaches tipping point

April 2, 2009 Research and Development, Sales and Marketing digi, healthcare

Analysts Datamonitor believe that telehealth has reached the tipping point in terms of awareness, with IBM following Intel's entrance into …
News

Takeda chooses US base for its global development headquarters

April 2, 2009 Research and Development Takeda

Takeda Pharmaceutical Company is shifting its global development HQ from Japan to the US. The move will see that function …
News

CROs under pressure as early-stage pipelines dry up

March 27, 2009 Research and Development Pharmsource

There was a sharp slowdown in pharmaceutical outsourcing in the last six months which "really caught a lot of people …
News

GSK pledges further trial transparency

March 26, 2009 Research and Development, Sales and Marketing GSK

GlaxoSmithKline is to make its clinical trials more transparent through a series of moves it believes will facilitate clinical research. …
News

NICE recommends Pfizer’s Sutent

March 26, 2009 Research and Development NICE, Pfizer, Sutent

NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …
News

GlaxoSmithKline and UCL to develop biologic

March 24, 2009 Research and Development GSK

Researchers at University College London are to work with GlaxoSmithKline to develop a new treatment for the rare and often …
News

Merck Serono sets up biotech fund

March 24, 2009 Research and Development Merck Serono, biotech

Merck Serono has set up a venture capital fund to invest in emerging biotech companies working in its core therapy …
News

Biosimilars: time for an approval pathway in the US

March 23, 2009 Research and Development, Sales and Marketing US, generics

Congress has received another bill seeking to establish a biosimilars approval pathway in the US. HR 1427 represents the latest …
News

Bayer strikes R&D deal with Chinese university

March 20, 2009 Research and Development Bayer, China, academic research

 Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua …
News

Shire withdraws ADHD patch filing

March 19, 2009 Research and Development, Sales and Marketing Shire

Shire has withdrawn the European marketing application for its Attention Deficit Hyperactivity Disorder (ADHD) patch product Daytrana. The product's active …
News

Sanofi boosted by Multaq vote of approval

March 19, 2009 Research and Development, Sales and Marketing FDA, Multaq, Sanofi, US

An FDA committee has recommended Sanofi-Aventis' new atrial fibrillation treatment Multaq, the company's most important late-stage drug. The FDA cardiovascular …
News

FDA to review Xarelto safety concerns

March 19, 2009 Research and Development, Sales and Marketing Xarelto

Anti-blood clotting drug Xarelto could fail to win approval in the US due to safety concerns. The FDA has convened …
News

Biosimilars bill offers 12 years’ marketing exclusivity

March 19, 2009 Research and Development US, generics

The US moved one step closer to creating a market for biosimilars – substitutable versions of branded biologic drugs – …
News

Hamburg appointed as new FDA head

March 18, 2009 Research and Development FDA

A leading public health expert has been appointed as the new head of the FDA. President Obama has selected Dr …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026